BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8932796)

  • 1. Mismatched transplant for acute lymphoblastic leukemia.
    Aversa F
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():36-9. PubMed ID: 8932796
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion.
    Cornish JM; Pamphilon DH; Potter MN; Steward CG; Goodman S; Green A; Goulden P; Goulden N; Knechtli C; Hale G; Waldmann H; Oakhill A
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():31-5. PubMed ID: 8932795
    [No Abstract]   [Full Text] [Related]  

  • 4. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
    Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M
    Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
    Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
    Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
    Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
    Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute lymphoblastic leukemia in childhood treated with non-T-cell depleted bone marrow transplantation from an HLA 2 loci (HLA-A and-DRB1)-mismatched mother after early graft failure of cord blood transplantation].
    Ishida H; Mori K; Yoshihara T; Shin N; Morimoto A; Imashuku S
    Rinsho Ketsueki; 2003 Nov; 44(11):1101-6. PubMed ID: 14689875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Frassoni F; Sanz G; Demeocq F; Prentice H; Cahn JY; Barbui T; Meloni G; Schaefer U; Reiffers J; Gorin N
    Bone Marrow Transplant; 1999 Aug; 24(4):389-96. PubMed ID: 10467328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
    J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
    Chim CS; Lie AK; Liang R; Au WY; Kwong YL
    Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
    Balduzzi A; De Lorenzo P; Schrauder A; Conter V; Uderzo C; Peters C; Klingebiel T; Stary J; Felice MS; Magyarosy E; Schrappe M; Dini G; Gadner H; Valsecchi MG
    Haematologica; 2008 Jun; 93(6):925-9. PubMed ID: 18413892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia.
    Singhal S; Powles R; Henslee-Downey PJ; Chiang KY; Treleaven J; Godder K; Kulkarni S; van Rhee F; Sirohi B; Pinkerton CR; Meller S; Mehta J
    Bone Marrow Transplant; 2002 Feb; 29(4):291-5. PubMed ID: 11896425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute leukemia in Jehovah's Witnesses: a challenge for hematologists.
    Mazza P; Palazzo G; Amurri B; Cervellera M; Rizzo C; Maggi A
    Haematologica; 2000 Nov; 85(11):1221-2. PubMed ID: 11064477
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.
    Liu D; Tammik C; Zou JZ; Ernberg I; Masucci MG; Ringden O; Levitsky V
    Clin Transplant; 2004 Oct; 18(5):518-24. PubMed ID: 15344953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemia.
    Aversa F; Terenzi A; Felicini R; Tabilio A; Falzetti F; Carotti A; Falcinelli F; Sodani P; Amici A; Zucchetti P; Mazzarino I; Martelli MF
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S29-32. PubMed ID: 9989886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical transplantation for acute lymphoblastic leukemia in childhood.
    Klingebiel T; Handgretinger R; Lang P; Bader P; Niethammer D
    Blood Rev; 2004 Sep; 18(3):181-92. PubMed ID: 15183902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cord blood transplantation for children with acute leukaemia: a Eurocord registry analysis.
    Gluckman E; Rocha V
    Blood Cells Mol Dis; 2004; 33(3):271-3. PubMed ID: 15528143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.